Correspondence on: "Real-world safety data of first-line drugs for rheumatoid arthritis: insights from the Portuguese Reuma.pt database".
This correspondence addresses methodological considerations in a study analyzing adverse event (AE) reports from the Portuguese Reuma.pt registry on first-registered disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis (RA). It highlights the need for reporting exposure denominato...
| Published in: | ARP Rheumatology Vol. 5; no. 2; pp. 135 - 138 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Published: |
Sociedade Portuguesa de Reumatologia
Apr-Jun2026
|
| Subjects: | |
| Online Access: | View this record in EBSCOhost |